Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page
- Check6 days agoChange DetectedThe study page now shows recruitment status as 'No longer looking for participants', and adds help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The 'Intervention/Treatment' heading formatting has changed and the site revision tag updated to v3.6.0.SummaryDifference0.4%

- Check13 days agoChange DetectedAn administrative revision update was applied, replacing v3.5.4 with v3.5.5 on the page. This change does not modify any study content, eligibility criteria, or results.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe revision label on the page has been updated from v3.5.3 to v3.5.4, indicating a backend/site update rather than a change to the study data.SummaryDifference0.1%

- Check56 days agoChange DetectedThe ClinicalTrials.gov page revision label was updated from **v3.5.2** to **v3.5.3**, indicating a website/platform release rather than a change to the study information.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3 tag.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.